Warning Cookies are used on this site to provide the best user experience. If you continue, we assume that you agree to receive cookies from this site. OK

M.D. Věra Dolejšová

Penoxal and its indication in my patients is always tested using the device EAV – Portable, from Embitron. I use the same test for establishing the daily dose. I have used the product in 15 patients.

8 patients diagnosed with mammary gland Ca and treated with chemotherapy

All the patients used 2 tbl daily, they tolerated chemo well, and I added some homeopathics. They reported significantly lower fatigue compared to other patients, and a quicker recovery of their body. Penoxal has no effect on hair loss.

1 patient diagnosed with generalised Ca, primary in colon, no conventional treatment

The patient takes Penoxal 4 tbl per day together with beta-glucan; he feels well, reports no pain, tumour markers have been mildly reduced after 3 months.

2 patients diagnosed with mammary gland Ca, prior to treatment so far
The patients report no pain; they feel calmer, tumour markers are stable - i.e. the process has either stopped or slowed down.

2 patients with chronic fatigue syndrome, no conventional treatment
These patients are on Penoxal 50 mg 2tbl/day, homeopathic drainage and some homeopathics for psychological wellbeing. When adding Penoxal, they reported quicker regeneration after work.

1 patient diagnosed with chronic lymphatic leukaemia, no conventional treatment so far

In this case there was a decline of lab leukocyte values 1 month after the treatment started; currently the patient reports no problems. The next follow-up is in 2 months.

Conclusion:

According to EAV test, Penoxal is more suitable for degenerative diseases.

M.D. Věra Dolejšová
Internal Medicine Outpatients
Dejvická 919/38
160 00 Praha-Bubenec

The doctor´s evaluation in pdf for download below the text